TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 78 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI
Grant: HL139819,HL141256,HL138014,HL152174
NHLBI NIH HHS
Grant: R01 HL139819
NHLBI NIH HHS
Grant: R01 HL152174
NHLBI NIH HHS
Grant: R01 HL138014
NHLBI NIH HHS
Grant: R01 HL141256
NHLBI NIH HHS
Grant: R01 HL142650
National Institutes of Health
Grant: 5R01HL138014-03
Somatic TET2 mutations in cardiac remodeling
National Institutes of Health
Grant: 1R01HL141256-01A1
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease
National Institutes of Health
Grant: 1R01HL139819-01A1
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals